Page 4 - Trial Protocol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency use. The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support. The company on Monday said the clinical trial was initiated in November at BJ G...

Share this article HOUSTON, Feb. 18, 2021 /PRNewswire/ -- WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) ("WPD") and CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), biopharmaceutical companies specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that WPD Pharmaceuticals received a positive opinion of the Lower Silesian Medical Chamber Ethics Committee in Wrocław, Poland for its planned upcoming Berubicin clinical trial in adults with Glioblastoma Muliforme (GBM) under the WPD-201 Clinical...

Updated Jan 03, 2021 | 13:22 IST The drug regulator has given a conditional nod to SII's Covishield and Bharat Biotech's Covaxin. Permission was also granted for Cadila Healthcare's Phase 3 trials. Representational Image  Drug Regulator accepts SEC's recommendations, gives conditional nod for Covishield, Covaxin PM hails the nod for SII & Bharat Biotech vaccines as a decisive turning point in fight against COVID 2021 promises to the year of vaccination in India and elsewhere Looking back, we didn’t know what was coming when 2020 descended upon us. Whi...

URL copied Expert panel recommends granting restricted emergency use approval for COVAXIN. A day after a government panel recommended to grant emergency use approval for the Oxford-AstraZeneca's Covishield vaccine for coronavirus, an expert panel on Saturday recommended granting permission for restricted emergency use authorisation for Bharat Biotech's indigenously developed COVID-19 vaccine — Covaxin, ANI reported quoting government sources. The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergen...